Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
6 resultat
Indole derivatives with affinity for the cannabinoid receptor
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
The terms cannabinoid or cannabimimetic compound apply to compounds which produce a physiological effect similar to that of the plant Cannabis Sativa, or a compound that has affinity for the cannabinoid receptors CB.sub.1 or CB.sub.2. See Matsuda, L.; Lolait, S. J.;
Immunoassay for synthetic cannabinoids of the adamantyl indazole/indole-3-carboxamide family
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS REFERENCE TO RELATED APPLICATIONS
This application claims the priority benefit of the earlier filing date of Great Britain Application No. 1409464.3, filed on 28 May 2014 and Great Britain Application No. 1409514.5, filed on 29 May 2014, both of which are specifically incorporated herein by
Indoles are cannabinoid receptor ligands
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The present invention relates to indole derivatives, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
BACKGROUND OF THE INVENTION
(-)-.DELTA..sup.9-Tetrahydrocannabinol (.DELTA..sup.9-THC), the major
Indoles are cannabinoid receptor ligands
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The present invention relates to indole derivatives, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
BACKGROUND OF THE INVENTION
(-)-.DELTA..sup.9-Tetrahydrocannabinol (.DELTA..sup.9-THC), the major
(Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The present invention relates to (indol-3-yl)-heterocycle derivatives, to pharmaceutical compositions comprising the same and to the use of these (indol-3-yl)-heterocycle derivatives in therapy, especially in the treatment of pain.
Pain treatment is often limited by the side effects of currently
Cannabinoid type 1 receptor modulators
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD
The present disclosure relates to compounds of the Formula (I) which are cannabinoid type 1 receptor modulators, and their use in the treatment of diseases in which modulation of the receptor is beneficial.
INTRODUCTION
The endocannabinoid system encompasses a family of endogenous eicosanoid
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
